复星医药-话题@MedSci

#复星医药#

14篇内容 | 821人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1533383, encodeId=cf9e15333839e, content=<a href='/topic/show?id=0dec4268035' target=_blank style='color:#2F92EE;'>#复星医药#</a>, objectTitle=2022年4月28日简报：美国CDC和欧盟认为其人口60%感染过新冠病毒，福奇称美国已走出大流行阶段；中国台湾新增8923例新冠确诊病例；未来复星医药和沃森生物旗下mRNA疫苗一起获批紧急使用的可能性较大, objectType=article, longId=725668, objectId=a2b4e25668e9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a2b4e25668e9, replyNumber=0, likeNumber=47, createdTime=2022-04-29, rootId=0, userName=zhs3886, userId=065812431582, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a2b4e25668e9, moduleTitle=2022年4月28日简报：美国CDC和欧盟认为其人口60%感染过新冠病毒，福奇称美国已走出大流行阶段；中国台湾新增8923例新冠确诊病例；未来复星医药和沃森生物旗下mRNA疫苗一起获批紧急使用的可能性较大, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a2b4e25668e9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1533382, encodeId=45941533382cf, content=<a href='/topic/show?id=0dec4268035' target=_blank style='color:#2F92EE;'>#复星医药#</a>, objectTitle=复星医药上半年净利增44.77% ，海外收入占比突破30%, objectType=article, longId=216241, objectId=7eaf2162418c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7eaf2162418c, replyNumber=0, likeNumber=31, createdTime=2021-08-26, rootId=0, userName=zhs3886, userId=065812431582, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7eaf2162418c, moduleTitle=复星医药上半年净利增44.77% ，海外收入占比突破30%, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7eaf2162418c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1533381, encodeId=ceea153338142, content=<a href='/topic/show?id=0dec4268035' target=_blank style='color:#2F92EE;'>#复星医药#</a>, objectTitle=复星医药与BioNTech研发的新冠疫苗通过中国专家组审核, objectType=article, longId=214285, objectId=9f1121428517, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9f1121428517, replyNumber=0, likeNumber=32, createdTime=2021-07-17, rootId=0, userName=zhs3886, userId=065812431582, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9f1121428517, moduleTitle=复星医药与BioNTech研发的新冠疫苗通过中国专家组审核, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9f1121428517)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1533380, encodeId=99d21533380ad, content=<a href='/topic/show?id=0dec4268035' target=_blank style='color:#2F92EE;'>#复星医药#</a>, objectTitle=复星医药/BioNTech在中国设立合资公司：mRNA新冠疫苗复必泰年产能达10亿剂，预计7月前被国内批准上市, objectType=article, longId=211050, objectId=500e2110502a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=500e2110502a, replyNumber=0, likeNumber=35, createdTime=2021-05-11, rootId=0, userName=zhs3886, userId=065812431582, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=500e2110502a, moduleTitle=复星医药/BioNTech在中国设立合资公司：mRNA新冠疫苗复必泰年产能达10亿剂，预计7月前被国内批准上市, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=500e2110502a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1533379, encodeId=a35215333e9ce, content=<a href='/topic/show?id=0dec4268035' target=_blank style='color:#2F92EE;'>#复星医药#</a>, objectTitle=复星医药产业拟超7.42亿元受让重庆药友约10.04%股权, objectType=article, longId=200500, objectId=43d320050002, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=43d320050002, replyNumber=0, likeNumber=25, createdTime=2020-09-11, rootId=0, userName=zhs3886, userId=065812431582, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=43d320050002, moduleTitle=复星医药产业拟超7.42亿元受让重庆药友约10.04%股权, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=43d320050002)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1533378, encodeId=9de815333e8fb, content=<a href='/topic/show?id=0dec4268035' target=_blank style='color:#2F92EE;'>#复星医药#</a>, objectTitle=复星医药引进的新冠mRNA疫苗获批临床了, objectType=article, longId=197807, objectId=4ad419e80746, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4ad419e80746, replyNumber=0, likeNumber=31, createdTime=2020-07-22, rootId=0, userName=zhs3886, userId=065812431582, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4ad419e80746, moduleTitle=复星医药引进的新冠mRNA疫苗获批临床了, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4ad419e80746)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1533377, encodeId=bd5a15333e75c, content=<a href='/topic/show?id=0dec4268035' target=_blank style='color:#2F92EE;'>#复星医药#</a>, objectTitle=复星医药新开发的白血病药物FN-1501获得FDA孤儿药称号, objectType=article, longId=183900, objectId=823f18390056, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=823f18390056, replyNumber=0, likeNumber=26, createdTime=2019-12-02, rootId=0, userName=zhs3886, userId=065812431582, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=823f18390056, moduleTitle=复星医药新开发的白血病药物FN-1501获得FDA孤儿药称号, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=823f18390056)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1533376, encodeId=c70115333e6d6, content=<a href='/topic/show?id=0dec4268035' target=_blank style='color:#2F92EE;'>#复星医药#</a>, objectTitle=复星医药子公司1.48亿美元引进胶质母细胞瘤治疗药物, objectType=article, longId=183110, objectId=78d91831105f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=78d91831105f, replyNumber=0, likeNumber=36, createdTime=2019-11-19, rootId=0, userName=zhs3886, userId=065812431582, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=78d91831105f, moduleTitle=复星医药子公司1.48亿美元引进胶质母细胞瘤治疗药物, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=78d91831105f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1533375, encodeId=485815333e58d, content=<a href='/topic/show?id=0dec4268035' target=_blank style='color:#2F92EE;'>#复星医药#</a>, objectTitle=复星医药董事长陈启宇：抗癌创新药降价是必经之路, objectType=article, longId=178563, objectId=65711e856307, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=65711e856307, replyNumber=0, likeNumber=35, createdTime=2019-09-03, rootId=0, userName=zhs3886, userId=065812431582, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=65711e856307, moduleTitle=复星医药董事长陈启宇：抗癌创新药降价是必经之路, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=65711e856307)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1533374, encodeId=fb3115333e4cb, content=<a href='/topic/show?id=0dec4268035' target=_blank style='color:#2F92EE;'>#复星医药#</a>, objectTitle=复星医药进军干细胞产业，巨资引入干细胞治疗脑中风后遗症等两款国外在研细胞产品, objectType=article, longId=164023, objectId=59311640238f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=59311640238f, replyNumber=0, likeNumber=36, createdTime=2019-04-12, rootId=0, userName=zhs3886, userId=065812431582, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=59311640238f, moduleTitle=复星医药进军干细胞产业，巨资引入干细胞治疗脑中风后遗症等两款国外在研细胞产品, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=59311640238f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1533373, encodeId=1e8615333e3c5, content=<a href='/topic/show?id=0dec4268035' target=_blank style='color:#2F92EE;'>#复星医药#</a>, objectTitle=回应“举报”门复星医药称“经得起查”, objectType=article, longId=147999, objectId=eed614e99925, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=eed614e99925, replyNumber=0, likeNumber=26, createdTime=2018-09-02, rootId=0, userName=zhs3886, userId=065812431582, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=eed614e99925, moduleTitle=回应“举报”门复星医药称“经得起查”, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=eed614e99925)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1533372, encodeId=9c7c15333e29e, content=<a href='/topic/show?id=0dec4268035' target=_blank style='color:#2F92EE;'>#复星医药#</a>, objectTitle=复星医药再下一城投资改制绵阳三甲医院, objectType=article, longId=114081, objectId=ab4e11408148, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ab4e11408148, replyNumber=0, likeNumber=37, createdTime=2017-09-27, rootId=0, userName=zhs3886, userId=065812431582, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ab4e11408148, moduleTitle=复星医药再下一城投资改制绵阳三甲医院, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ab4e11408148)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1533371, encodeId=03c415333e187, content=<a href='/topic/show?id=0dec4268035' target=_blank style='color:#2F92EE;'>#复星医药#</a>, objectTitle=复星医药携手Kite进军癌症T细胞免疫治疗市场, objectType=article, longId=87290, objectId=35c18e2905e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=35c18e2905e, replyNumber=0, likeNumber=45, createdTime=2017-01-13, rootId=0, userName=zhs3886, userId=065812431582, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=35c18e2905e, moduleTitle=复星医药携手Kite进军癌症T细胞免疫治疗市场, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=35c18e2905e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1533370, encodeId=c01015333e0dc, content=<a href='/topic/show?id=0dec4268035' target=_blank style='color:#2F92EE;'>#复星医药#</a>, objectTitle=复星医药第11个抗疟药通过世界卫生组织PQ认证, objectType=article, longId=43160, objectId=4d28431606e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4d28431606e, replyNumber=0, likeNumber=30, createdTime=2014-11-28, rootId=0, userName=zhs3886, userId=065812431582, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4d28431606e, moduleTitle=复星医药第11个抗疟药通过世界卫生组织PQ认证, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4d28431606e)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

复星医药

2020-05-29

zhs3886 (审核中...)

前往app查看评论内容

#复星医药#

2022年4月28日简报：美国CDC和欧盟认为其人口60%感染过新冠病毒，福奇称美国已走出大流行阶段；中国台湾新增8923例新冠确诊病例；未来复星医药和沃森生物旗下mRNA疫苗一起获批紧急使用的可能性较大

2022-04-29

zhs3886 (审核中...)

前往app查看评论内容

#复星医药#

复星医药上半年净利增44.77% ，海外收入占比突破30%

2021-08-26

zhs3886 (审核中...)

前往app查看评论内容

#复星医药#

复星医药与BioNTech研发的新冠疫苗通过中国专家组审核

2021-07-17

zhs3886 (审核中...)

前往app查看评论内容

#复星医药#

复星医药/BioNTech在中国设立合资公司：mRNA新冠疫苗复必泰年产能达10亿剂，预计7月前被国内批准上市

2021-05-11

zhs3886 (审核中...)

前往app查看评论内容

#复星医药#

复星医药产业拟超7.42亿元受让重庆药友约10.04%股权

2020-09-11

zhs3886 (审核中...)

前往app查看评论内容

#复星医药#

复星医药引进的新冠mRNA疫苗获批临床了

2020-07-22

zhs3886 (审核中...)

前往app查看评论内容

#复星医药#

复星医药新开发的白血病药物FN-1501获得FDA孤儿药称号

2019-12-02

zhs3886 (审核中...)

前往app查看评论内容

#复星医药#

复星医药子公司1.48亿美元引进胶质母细胞瘤治疗药物

2019-11-19

zhs3886 (审核中...)

前往app查看评论内容

#复星医药#

复星医药董事长陈启宇：抗癌创新药降价是必经之路

2019-09-03

zhs3886 (审核中...)

前往app查看评论内容

#复星医药#

复星医药进军干细胞产业，巨资引入干细胞治疗脑中风后遗症等两款国外在研细胞产品

2019-04-12

zhs3886 (审核中...)

前往app查看评论内容

#复星医药#

回应“举报”门复星医药称“经得起查”

2018-09-02

zhs3886 (审核中...)

前往app查看评论内容

#复星医药#

复星医药再下一城投资改制绵阳三甲医院

2017-09-27

zhs3886 (审核中...)

前往app查看评论内容

#复星医药#

复星医药携手Kite进军癌症T细胞免疫治疗市场

2017-01-13

zhs3886 (审核中...)

前往app查看评论内容

#复星医药#

复星医药第11个抗疟药通过世界卫生组织PQ认证

2014-11-28

科室
- - 订阅+
  - 更多科室
工具
服务